Antihistamine OTC Switch Unlikely To Increase Consumer Costs - Insurer
Executive Summary
Moving prescription low- and non-sedating, second-generation antihistamines to over-the-counter availability would be unlikely to increase out-of-pocket costs for U.S. consumers based upon OTC pricing of the drugs in foreign countries, Blue Cross of California/WellPoint Health Networks VP Pharmacy Robert Seidman told an FDA public hearing on OTC switches June 29.